QDEL - MCAP CO - QuidelOrtho

QuidelOrtho (QDEL) produces diagnostic systems, leveraging demand for infectious disease tests and regulatory approvals. The company strives for global leadership in rapid testing by deploying Sofia readers to generate steady recurring revenue from consumables. Analyzer production is fully automated using robotics and optical inspection. Current market capitalization stands at 0.74. This price chart clearly demonstrates the market dynamics of the business.

Market capitalization reflects the aggregate value of all company shares, determining its current sector weight by multiplying the market price of a single instrument by the total number of issued securities. An analysis of the share capitalization of QuidelOrtho (QDEL) allows for an assessment of its investment attractiveness, where stable demand for diagnostic systems and the operation of plants in the US and Europe support the resilience of this fundamental metric.